Development and marketing of pharmaceutical medicines in nephrology, cardiology, urology, and gastroenterology.
Annual revenue $138,105 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Biocent

Biocent is a company. Biocent offers products and services including Nephrology Medicines and Cardiology Medications.

Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $138.11 K (USD)
    53.82
    as on Mar 31, 2022
  • Net Profit
    $10.88 K (USD)
    87.85
    as on Mar 31, 2022
  • EBITDA
    $19.03 K (USD)
    24.74
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Biocent

Biocent offers a comprehensive portfolio of products and services, including Nephrology Medicines and Cardiology Medications.

Product name locked
Category locked
Primary

Medicines for kidney-related diseases are developed and marketed by Biocent in areas like chronic kidney disease.

Product name locked
Category locked
Locked

Cardiovascular medications are provided by Biocent for conditions such as hypertension and heart failure.

Funding Insights of Biocent

Premium access

Detailed funding history for Biocent

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Biocent

Investments
Premium access

Investment portfolio details for Biocent

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Biocent

Premium access

Detailed financials for Biocent

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Biocent Comparisons

Biocent Primary company
Description
Development and marketing of pharmaceutical medicines in nep...
Location
-
Founded Year
-
Annual Revenue
$138.11 K (USD)
Net Profit
$10.88 K (USD)
EBITDA
$19.03 K (USD)
Employees
Not available
Premium access

Peer comparison for Biocent

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Biocent

Premium access

Detailed competitors of Biocent

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Biocent

Premium access

Complete news archive for Biocent

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biocent

Annual revenue of Biocent is $138.11K as on Mar 31, 2022.

Biocent is recognized as a pharmaceutical company that develops, manufactures, and markets high-quality medicines in key therapeutic areas such as nephrology, cardiology, urology, and gastroenterology. Innovation is emphasized through research and development efforts that focus on novel drug delivery systems to enhance patient outcomes. Quality control is maintained by adhering to global standards like GMP and ISO certifications, ensuring safety and efficacy. Partnerships with healthcare professionals are fostered to address unmet medical needs, while corporate social responsibility initiatives are undertaken to improve healthcare access and promote health education. Overall, a commitment to integrity and excellence is demonstrated in operations that aim to benefit patients and communities.

Biocent offers Nephrology Medicines and Cardiology Medications.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available